Company
Forward Pharma A/S
Headquarters: Copenhagen, Denmark
Employees: 4
CEO: Dr. Claus Bo Søndergaard Svendsen
Market Cap
$13.8 Million
USD as of Feb. 1, 2023
Forward Pharma A/S Categories
Denmark
languages
Healthcare
languages
Biotechnology
Denmark Healthcare
Denmark Biotechnology
Top Competitors by Market Capitalization
Industry: Biotechnology
| Company | Market Cap (USD) |
|---|---|
|
Novo Nordisk
|
$329.83 B |
Vertex Pharmaceuticals Incorporated
|
$88.79 B |
CSL Limited
|
$85.00 B |
| Marinomed Biotech AG | $84.73 B |
|
Regeneron Pharmaceuticals, Inc.
|
$78.88 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
|
UnitedHealth Group
|
$428.70 B |
|
Lilly
|
$417.05 B |
|
Johnson & Johnson
|
$412.24 B |
|
Novo Nordisk
|
$329.83 B |
|
Merck
|
$275.82 B |
Detailed Description
Forward Pharma A/S does not have significant operations. Previously, it operated as a biopharmaceutical company that focused on developing proprietary formulation of dimethyl fumarate for the treatment of inflammatory and neurological indications. The company was incorporated in 2005 and is headquartered in Copenhagen, Denmark.
Unlock the Power of Financial AI:
Try Disfold AI Free for 7 Days!
Stocks & Indices
Forward Pharma A/S has the following listings and related stock indices.
Stock: NASDAQ: FWP wb_incandescent
Stock: FSX: 1FPB wb_incandescent